B. Riley Securities Initiates Coverage On Veradermics with Buy Rating, Announces Price Target of $170

Benzinga · 2d ago
B. Riley Securities analyst Mayank Mamtani initiates coverage on Veradermics (NYSE:MANE) with a Buy rating and announces Price Target of $170.